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eluting
stentEverlimus-
eluting
stentBiodegradable
polymer stentEndothelial cell
capture coating
stentP-value(N [ 372) (N [ 405) (N [ 300) ( N [ 440)Clinical characteristicsAge, years 61.8  12.2 61.3  13.4 61.0  11.6 62.1 11.7 0.638
Male sex 282 (76%) 313(77%) 247(82%) 347(79%) 0.211Body mass index 24.2  3.3 24.2  3.3 24.1  2.9 24.1  3.2 0.969
Diabetes 108 (29%) 112 (27%) 72 (24%) 111 (25%) 0.422Hypertension 178 (48%) 210 (52%) 144 (48$) 215 (49%) 0.739Hyperlipidemia 97 (26%) 118 (29%) 72 (24%) 139 (32%) 0.104Previous PCI 38 (10%) 33 (8%) 13 (4%) 23 (5%) 0.007Previous
myocardial
infarction32 (9%) 16 (4%) 12 (4%) 17 (4%) 0.005Previous
congestive
heart failure9 (2%) 10 (3%) 3 (1%) 5 (1%) 0.258Previous CABG 5 (1%) 3 (1%) 1 (1%) 0 (0%) 0.083Chronic renal
failure8 (2%) 9 (2%) 5 (2%) 8 (2%) 0.944Peripheral
vascular
disease4 (1%) 3 (1%) 1 (1%) 1 (1%) 0.398Chronic
obstructive
pulmonary
disease10 (3%) 15 (4%) 5 (2%) 8 (2%) 0.253Angiographic characteristicsNumber of
diseased
vessels< 0.001Single vessel
disease170 (46%) 221 (54%) 174 (58%) 271 (62%)Two vessel
disease111 (30%) 109 (27%) 79 (26%) 117 (27%)Triple vessel
disease78 (21%) 59 (15%) 42 (14%) 46 (11%)Left main
involvement13 (4%) 19 (5%) 5 (2%) 6 (1%)Multivessel
disease202 (54%) 187 (46%) 126 (42%) 169 (38%) < 0.001Procedure characteristicsNumber of stent 1.6  0.9 1.6  0.9 1.3  0.6 1.4  0.5 < 0.001
Average
diameter of
stent (mm)3.2 0.5 3.4 0.6 3.3 0.6 3.5 0.6 <0.001Total stent
length (mm)42.5 25.7 35.5 21.9 27.8 14.2 29.3 14.7 <0.001Antiplatelet agentDual antiplatelet
agent at
discharge350
(99.4%)378
(99.0%)264 (92%) 391
(94.2%)< 0.001Table 2. Cumulative incidence rate of clinical outcome at 2 yearsTCTAP A-009
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BACKGROUND The aimof this studywas to evaluate the clinical outcome
of preventive angioplasty in ST-elevation Myocardial Infarction.
S6 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5METHODS From the IRIS-DES registry, we identiﬁed 683 patients
treated using stent with ST-elevation myocardial infarction (STEMI)
who had multivessel disease. A total 212 patients was underwent
infarct-artery percutaneous coronary intervention (PCI) alone, and a
471 patients was underwent preventive PCI. Major adverse cardiac
events (MACE) were deﬁned using composite of death, myocardial
infarction, and target vessel revascularization (TVR).
RESULTS During follow up (median 2 years), culprit only PCI versus
preventive PCI was no signiﬁcant difference in MACE cumulative
incidence(11.4% vs. 12.5%, Hazard ratio[HR], 95% conﬁdence interval
[CI] 0.89 (0.55 – 1.45), P ¼ 0.652), death (6.0% vs. 7.1%, 0.86 (0.45 –
1.65), P ¼ 0.653), MI (1.6% vs. 7.1%, 1.11 (0.27 – 4.60), P ¼ 0.876), and
TVR (8.5% vs. 12.0%, 0.65 (0.38 – 1.12), P ¼ 0.121). The cumulative
rates of Academic Research Consortium deﬁned deﬁnite stent
thrombosis were 1.0% in Only culprit PCI group and 0.9% in preven-
tive PCI group (P ¼ 0.901).
CONCLUSION In our registry study, the preventive PCI in STEMI
cannot contribute to improve clinical outcome, including death, MI,
and TVR. A preventive angioplasty strategy of nonculprit lesions in
STEMI remains controversial.
Table 1. Characteristics of Study Patients Undergoing PCI of the ULMCANo AOC (N[238) AOC (N[623) P-valueAge (years) 62.3410.97 63.929.47 0.231
Gender (Male) 45(18.9) 174(27.9) 0.007Hypertension 144(60.5) 356(57.1) 0.371Diabetes 85(35.7) 216(34.7) 0.774LV ejection fraction (%) 57.39.72 59.67.64 0.035
Aorto-ostial lesion 5(2.1) 307(49.3) 0.001At least one chronic total occlusion 7(2.9) 6(1) 0.033At least one severe calciﬁcation 14(5.9) 21(3.4) 0.095At least one thrombus present 12(5) 26(4.2) 0.579At least one ulceration 11(4.6) 13(2.1) 0.043Reference diameter (mm) 3.580.44 3.70.42 0.001
Lumen diameter stenosis (%) 61.8332.8 64.7926.5 0.171
Total number of stents 2.891.4 2.681.5 0.301
Total stent length 70.3239.7 63.0838.1 0.158
Maximal balloon inﬂation size 3.940.3 4.080.4 0.004Data are N (%), meanSD; AOC, aorto-ostial coverageTCTAP A-010
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BACKGROUND Acute coronary syndrome (ACS) refers to symptoms
attributed to obstruction of the coronary arteries, and is associated
with coronary thrombosis. In ACS patients, revascularization within
the time of guideline recommendation is critical to improve prog-
nosis, where in real situation, however, patients with appropriate
treatment are minor. Diagnostic dilemma is one of the important
reasons of reperfusion delay. Despite well trained physicians and
diagnostic tools, diagnosing ACS early in the emergency department
(ED) remains a challenge. In this study, we investigate the possi-
bility of predicting ACS using machine learning algorithms at an
early stage using clinical and laboratory data in patients who pre-
sented a chest pain at admission of emergency room or outpatients
clinic.
METHODS We obtained 2,344 ACS patient and 6289 non-ACS patient
data, and 27 features are selected for ACS prediction. Among the non-
ACS, patients, coronary artery spasm (CAS) was 2,738 patients. A
standard algorithm, linear discriminant analysis (LDA) is used for
prediction, and the classiﬁcation accuracy of ACS and non-ACS pa-
tients is reported as well as the analysis which features are more
relevant. Based on the feature pattern and ﬁlter characteristics, we
can analyze which features possess the discriminative information
while other features help improve accuracy by reducing noise of
features with discriminative information.
RESULTS The accuracy of classiﬁcation is average of 0.81 for non-
trained data, and we could select relevant features of classiﬁcation as
well as the features without discriminative information but reducing
noise of relevant features. Even when we eliminate the relevant fea-
tures chosen at ﬁrst stage, the less-informative features still have
discriminative information achieving the accuracy of 0.81.
CONCLUSION The risk group of ACS patients can be selected
before emergency using prediction algorithm, and the accuracy is
high. However, in this study, there were several missing data,
which is related to predict ACS. Therefore, in the future, a large
cohort study without missing data should be needed to get a ﬁnal
result.
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BACKGROUND It is reported that emergency procedure and two-stent
procedure at the bifurcation lesion are high risk factors for sub-acute
stent thrombosis (SAT). However, the impacts of presence or absence of
ST-segment elevation in acute coronary syndrome (ACS) patients and
two-stent procedure in those patients are little known. We compared
